object
aim
investig
clinic
featur
manag
patient
wuxi
especi
sever
method
epidemiolog
demograph
clinic
laboratori
imag
treatment
outcom
data
patient
collect
followup
last
april
result
patient
includ
nonsever
patient
sever
patient
common
comorbid
hypertens
diabet
common
symptom
fever
cough
sputum
lymphopenia
common
laboratori
find
groundglass
opac
common
chest
ct
featur
patient
receiv
antivir
therapi
interferon
inhal
lopinavirritonavir
tablet
common
complic
includ
acut
liver
injuri
respiratori
failur
patient
discharg
death
occur
medic
staff
got
infect
patient
sever
show
significantli
older
age
decreas
lymphocyt
increas
c
reactiv
protein
higher
frequenc
bilater
lung
infiltr
compar
nonsever
patient
significantli
treatment
includ
antibiot
therapi
mechan
ventil
longer
hospit
stay
higher
cost
shown
sever
patient
conclus
studi
suggest
patient
sever
may
like
older
age
present
lymphopenia
bilater
lung
infiltr
receiv
multipl
treatment
stay
longer
hospit
health
care
peer
peopl
interest
retrospect
studi
investig
patient
wuxi
jiangsu
provinc
china
patient
diagnos
accord
interim
guidanc
chines
manag
guidelin
studi
approv
ethic
commiss
wuxi
fifth
peopl
hospit
design
infecti
diseas
hospit
inform
consent
particip
also
waiv
ethic
commiss
epidemiolog
demograph
clinic
laboratori
imag
treatment
outcom
data
retriev
electron
medic
record
patient
followup
studi
last
april
data
miss
vagu
confirm
direct
commun
health
care
provid
data
collect
two
independ
doctor
jxf
wh
check
anoth
doctor
tjx
identifi
laboratori
confirm
perform
hospit
wuxi
center
diseas
control
prevent
cdc
test
throat
swab
specimen
upper
respiratori
tract
use
standard
protocol
realtim
reversetranscriptas
polymeras
chain
reaction
rtpcr
assay
patient
receiv
routin
blood
examin
includ
complet
blood
count
liver
renal
function
test
coagul
test
cardiac
enzym
electrolyt
c
reactiv
protein
procalcitonin
arteri
blood
ga
analysi
chest
xray
ct
scan
also
done
everi
patient
criteria
discharg
bodi
temperatur
back
normal
level
day
signific
amelior
respiratori
symptom
obviou
improv
acut
lung
infiltr
chest
radiograph
two
consecut
throat
swab
sputum
specimen
test
neg
least
hour
apart
sever
defin
accord
chines
manag
guidelin
edit
severetyp
patient
character
dyspnea
respiratori
frequenc
blood
oxygen
satur
pao
fio
ratio
andor
lung
infiltr
within
hour
cluster
epidem
defin
least
two
confirm
case
asymptomat
infect
found
within
small
area
eg
famili
construct
site
work
unit
etc
within
day
exist
possibl
persontoperson
transmiss
due
close
contact
possibl
infect
due
coexposur
fever
defin
axillari
temperatur
diarrhea
diagnos
pass
loos
stool
time
per
day
isol
lower
respiratori
tract
specimen
blood
sampl
shock
defin
accord
third
intern
consensu
definit
continu
variabl
describ
use
median
interquartil
rang
iqr
comparison
group
perform
use
mannwhitney
u
test
categor
variabl
present
number
compar
test
fisher
exact
test
group
appropri
clinic
curv
develop
use
kaplanmei
method
logrank
test
twosid
less
consid
statist
signific
statist
analys
done
use
spss
version
graphpad
prism
version
shown
tabl
case
import
hubei
wuhan
due
longterm
live
shortterm
travel
wuhan
exist
case
epidem
cluster
among
patient
averag
approxim
case
per
cluster
mainli
famili
cluster
dine
cluster
median
incub
period
day
iqr
exposur
histori
incub
period
similar
patient
nonsever
sever
ill
describ
two
epidem
cluster
one
import
famili
cluster
one
combin
famili
transport
dine
cluster
figur
patient
live
togeth
wuhan
patient
patient
return
wuxi
januari
januari
respect
got
diagnos
admit
hospit
sinc
januari
patient
got
sever
diseas
figur
six
patient
could
first
one
get
infect
turn
transmit
viru
famili
member
patient
took
fight
back
wuxi
japan
januari
patient
famili
next
day
patient
dinner
patient
got
diagnosi
admiss
sinc
januari
patient
got
sever
diseas
figur
tabl
patient
sever
diseas
significantli
higher
frequenc
cough
vs
sputum
product
vs
dyspnea
vs
p
nonsever
diseas
admiss
patient
sever
diseas
significantli
lower
lymphocyt
l
vs
l
higher
c
reactiv
protein
vs
procalcitonin
vs
nonsever
diseas
concurr
groundglass
opac
present
patient
chest
ct
featur
patient
nonsever
sever
diseas
shown
figur
patient
receiv
antivir
therapi
interferon
inhal
lopinavirritonavir
tablet
tabl
significantli
patient
sever
diseas
respiratori
failur
nonsever
diseas
vs
p
patient
discharg
hospit
death
occur
median
durat
hospit
among
patient
day
iqr
tabl
patient
sever
diseas
longer
hospit
compar
nonsever
diseas
day
vs
day
ci
figur
patient
sever
diseas
also
stay
significantli
longer
hospit
neg
pcr
test
day
vs
day
ci
figur
median
hospit
cost
yuan
iqr
patient
sever
diseas
spent
significantli
money
nonsever
diseas
yuan
vs
yuan
p
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
knowledg
report
first
retrospect
studi
patient
wuxi
jiangsu
provinc
china
describ
epidemiolog
demograph
clinic
imag
featur
well
treatment
outcom
patient
patient
got
recoveri
discharg
hospit
death
occur
medic
staff
got
infect
studi
median
age
patient
sever
diseas
significantli
higher
compar
patient
nonsever
diseas
suggest
older
patient
may
suscept
get
sever
diseas
younger
patient
howev
signific
sex
differ
found
patient
nonsever
sever
ill
major
patient
got
infect
due
epidem
cluster
mostli
via
famili
dine
cluster
provid
evid
persontoperson
transmiss
accord
cluster
investig
technic
guidelin
chines
epidemiolog
work
group
epidem
cluster
divid
sever
subtyp
refer
cluster
famili
dine
work
unit
transport
public
place
half
patient
comorbid
hypertens
diabet
wherea
nt
discov
signific
differ
comorbid
patient
nonsever
sever
diseas
diabet
similarli
recent
studi
show
preval
diabet
averag
two
fold
higher
sever
case
common
symptom
found
studi
fever
cough
sputum
product
dyspnea
fatigu
chest
distress
headach
interestingli
found
patient
diarrhea
higher
incid
previou
studi
four
patient
sign
symptom
onset
got
nonsever
diseas
data
shown
exist
asymptomat
infect
individu
report
also
abil
viru
transmiss
other
particularli
patient
asymptomat
infect
may
realiz
ill
could
import
hidden
sourc
infect
may
bring
potenti
danger
public
health
therefor
great
signific
suspect
patient
fulli
cooper
selfisol
supervis
screen
laboratori
find
patient
sever
diseas
significantli
lower
level
lymphocyt
decreas
serum
sodium
concentr
well
higher
level
c
reactiv
protein
procalcitonin
nonsever
diseas
impli
abnorm
could
potenti
indic
severetyp
howev
unlik
studi
nt
find
major
differ
leukocyt
neutrophil
ddimer
liver
enzym
two
group
find
also
suggest
patient
sever
diseas
like
present
increas
neutrophil
ddimer
result
chest
ct
show
major
patient
bilater
infiltr
groundglass
opac
present
patient
sever
diseas
moreov
small
portion
patient
show
obviou
abnorm
ct
current
treatment
support
therapi
till
specif
drug
vaccin
approv
treatment
prevent
infect
studi
patient
receiv
combin
therapi
interferon
lopinavirritonavir
interferon
respons
broad
antivir
effect
enhanc
immun
respons
lopinavir
human
immunodefici
viru
type
aspart
proteas
inhibitor
previous
approv
treat
sarscov
infect
ritonavir
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
combin
lopinavir
increas
plasma
halflif
inhibit
cytochrom
surprisingli
recent
smallscal
clinic
trial
show
clinic
improv
observ
lopinavirritonavir
treatment
beyond
standard
care
treat
patient
sever
diseas
howev
deng
et
al
found
lopinavirritonavir
combin
arbidol
anoth
drug
sarscov
might
show
benefit
delay
clinic
progress
attenu
viral
transmiss
chloroquin
newli
recogn
potenti
effect
sarscov
studi
chloroquin
use
treat
four
patient
mostli
use
overal
need
take
long
time
identifi
invent
effect
medicin
data
patient
sever
diseas
like
treat
antibiot
therapi
intraven
system
corticosteroid
intraven
immun
globulin
thymosin
inject
probiot
tablet
lmwh
inject
highflow
oxygen
nasal
cannula
support
mechan
ventil
extent
may
explain
longer
durat
higher
cost
hospit
sever
patient
team
also
use
new
techniqu
treat
critic
sever
patient
transfus
convalesc
plasma
ecmo
even
lung
transplant
signific
differ
found
durat
convers
posit
pcr
test
neg
one
admiss
tabl
figur
howev
patient
sever
diseas
tendenc
stay
longer
hospit
neg
pcr
test
coronaviru
caus
prove
bind
entri
receptor
host
cell
call
angiotensinconvert
enzym
ii
previou
sarscov
merscov
protein
amino
acid
diffus
express
heart
vessel
lung
kidney
gut
function
convers
angiotensin
angiotensin
ii
play
pivot
role
reninangiotensinaldosteron
system
raa
infect
viru
predominantli
target
human
alveolar
type
result
pulmonari
symptom
report
associ
comorbid
symptom
complic
patient
hypertens
diabet
cardiovascular
diseas
gastrointestin
abnorm
howev
mechan
still
remain
unclear
chen
et
al
found
might
attack
pericyt
human
heart
thu
caus
capillari
endotheli
cell
dysfunct
lead
cardiovascular
diseas
cardiac
injuri
jin
et
al
suggest
gastrointestin
epitheli
cell
high
affin
indic
potenti
fecalor
transmiss
tendenc
gastrointestin
symptom
dissemin
despit
huge
relationship
whether
could
therapeut
target
still
remain
controversi
need
research
wuxi
potent
strict
measur
taken
sinc
outbreak
peopl
need
wear
face
mask
use
wuxi
health
code
go
peopl
wuhan
recent
close
contact
would
advis
quarantin
home
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
least
day
suspect
patient
would
receiv
nucleic
acid
pcr
test
got
posit
result
would
admit
hospit
immedi
everi
confirm
patient
would
arrang
neg
pressur
ward
design
infecti
hospit
treatment
got
discharg
still
need
pcr
test
two
four
week
discharg
respect
patient
one
patient
retest
posit
stool
sampl
sever
limit
exist
studi
first
studi
includ
case
thank
good
monitor
screen
wuxi
may
caus
statist
select
bia
result
second
immun
function
test
like
serum
cell
cytokin
test
like
serum
lactat
dehydrogenas
involv
laboratori
test
role
might
underestim
caus
sever
diseas
third
studi
limit
local
investig
find
may
inconsist
nationwid
worldwid
studi
may
decreas
credibl
summari
retrospect
studi
establish
epidemiolog
clinic
featur
patient
wuxi
jiangsu
provinc
china
share
success
experi
treatment
especi
patient
sever
diseas
result
support
persontoperson
transmiss
suggest
patient
sever
may
like
older
age
present
lymphopenia
bilater
lung
infiltr
receiv
multipl
treatment
stay
longer
hospit
larges
random
clinic
trial
urgent
need
identifi
effect
treatment
author
declar
compet
interest
chen
l
et
al
express
human
heart
indic
new
potenti
mechan
heart
injuri
among
patient
infect
cardiovasc
re
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
